Maine Medical Cannabis Program Expanded to Include PTSD

AUGUSTA, ME – Patients diagnosed with post-traumatic stress, Crohn’s disease, and other debilitating disorders will soon be eligible for cannabis therapy under legislation approved last week absent the Governor’s signature. Read this entire article.

In May, researchers at the Meir Medical Center in Israel reported that inhaling cannabis reduces symptoms of Crohn’s disease compared to placebo in patients non-responsive to traditional therapies. Investigators concluded, “Our data show that 8-weeks treatment with THC-rich cannabis, but not placebo, was associated with a significant decrease of 100 points in CDAI (Crohn’s Disease and activity index) scores.”

Clinical trial data published in the May issue of the journal Molecular Psychiatry theorized that cannabinoid-based therapies would likely comprise the “next generation of evidence-based treatments for PTSD (post-traumatic stress disorder).” Read more.

Photo Credit: http://www.thedailychronic.net

Comments are closed.